cbdMD (YCBD) Income towards Parent Company (2016 - 2026)
cbdMD (YCBD) posted Income towards Parent Company of -$283131.0 for Q4 2025, up 58.36% sequentially from -$679968.0 in Q3 2025, and down 1975.66% YoY from $15095.0 in Q4 2024.
cbdMD (YCBD) Income towards Parent Company (2016 - 2026) Analysis & Trends
cbdMD has reported Income towards Parent Company for 10 years, with the latest figure at -$283131.0 in Q4 2025.
- Quarterly Income towards Parent Company fell 1975.66% year-over-year to -$283131.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.3 million (up 13.0% YoY) and the FY2025 annual result came in at -$2.0 million, up 44.84% from the prior year.
- Income towards Parent Company rose to -$283131.0 in Q4 2025 per YCBD's latest filing, from -$679968.0 in the prior quarter.
- Over five years, Income towards Parent Company peaked at $459737.0 in Q2 2024 and troughed at -$31.6 million in Q2 2022.
- A 5-year average of -$5.8 million and a median of -$1.3 million in 2023 frame the typical range for Income towards Parent Company.
- The sharpest annual moves came in 2024 and 2025: Income towards Parent Company surged 125.97% in 2024, then plunged 1975.66% in 2025.
- Over 5 years, Income towards Parent Company stood at -$19.2 million in 2021, then surged by 79.35% to -$4.0 million in 2022, then surged by 74.81% to -$996501.0 in 2023, then soared by 101.51% to $15095.0 in 2024, then slumped by 1975.66% to -$283131.0 in 2025.
- According to Business Quant data, Income towards Parent Company over the past three periods registered -$283131.0, -$679968.0, and -$895272.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.13 Mn |
| Dec 31, 2025 | -283,131.00 |
| Sep 30, 2025 | -679,968.00 |
| Jun 30, 2025 | -895,272.00 |
| Mar 31, 2025 | -480,757.00 |
| Dec 31, 2024 | 15,095.00 |
| Sep 30, 2024 | -152,799.00 |
| Jun 30, 2024 | 459,737.00 |
| Mar 31, 2024 | -3.01 Mn |
| Dec 31, 2023 | -996,501.00 |
| Sep 30, 2023 | -15.87 Mn |
| Jun 30, 2023 | -1.77 Mn |
| Mar 31, 2023 | -1.34 Mn |
| Dec 31, 2022 | -3.96 Mn |
| Sep 30, 2022 | -14.63 Mn |
| Jun 30, 2022 | -31.63 Mn |
| Mar 31, 2022 | -4.66 Mn |
| Dec 31, 2021 | -19.16 Mn |
| Jun 30, 2020 | -7,781.00 |
| Dec 31, 2019 | -41,202.00 |